These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. What's in a name? The clinical features of facioscapulohumeral muscular dystrophy. Mul K; Lassche S; Voermans NC; Padberg GW; Horlings CG; van Engelen BG Pract Neurol; 2016 Jun; 16(3):201-7. PubMed ID: 26862222 [TBL] [Abstract][Full Text] [Related]
30. [Facioscapulohumeral muscular dystrophy with sinus dysfunction]. Shigeto H; Tamura T; Oya Y; Ogawa M; Kawai M Rinsho Shinkeigaku; 2002 Sep; 42(9):881-4. PubMed ID: 12710090 [TBL] [Abstract][Full Text] [Related]
31. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. Macaione V; Aguennouz M; Rodolico C; Mazzeo A; Patti A; Cannistraci E; Colantone L; Di Giorgio RM; De Luca G; Vita G Acta Neurol Scand; 2007 Feb; 115(2):115-21. PubMed ID: 17212615 [TBL] [Abstract][Full Text] [Related]
32. Atypical facet of Möbius syndrome: association with facioscapulohumeral muscular dystrophy. Kolski HK; Leonard NJ; Lemmers RJ; Bamforth JS Muscle Nerve; 2008 Apr; 37(4):526-9. PubMed ID: 18059038 [TBL] [Abstract][Full Text] [Related]
33. Bilateral Coats' response in a female patient leads to diagnosis of facioscapulohumeral muscular dystrophy. Bass SJ; Sherman J; Giovinazzo V Optometry; 2011 Feb; 82(2):72-6. PubMed ID: 21130700 [TBL] [Abstract][Full Text] [Related]
34. [Application of the Bgl II-Bln I dosage test to gene diagnosis of facioscapulohumeral muscular dystrophy 1A gene]. Su QX; Zhang C; Xie YM; Zeng Y; Liu XR; Lu XL; Zhu YZ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):245-7. PubMed ID: 15192827 [TBL] [Abstract][Full Text] [Related]
35. Facioscapulohumeral muscular dystrophy presenting with isolated axial myopathy and bent spine syndrome. Kottlors M; Kress W; Meng G; Glocker FX Muscle Nerve; 2010 Aug; 42(2):273-5. PubMed ID: 20658601 [TBL] [Abstract][Full Text] [Related]
36. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy]. Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163 [TBL] [Abstract][Full Text] [Related]
37. Modifications of brain tissue volumes in facioscapulohumeral dystrophy. Quarantelli M; Lanzillo R; Del Vecchio W; Mollica C; Prinster A; Iadicicco L; Iodice V; Santoro L; Salvatore M Neuroimage; 2006 Sep; 32(3):1237-42. PubMed ID: 16806975 [TBL] [Abstract][Full Text] [Related]
38. [A patient with dermatomyositis and systemic sclerosis with preferential facioscapulohumeral muscle involvement and fatal cardiomyopathy]. Oya Y; Toyama J; Ogawa M; Nonaka I; Kawai M Rinsho Shinkeigaku; 2001 Jun; 41(6):289-95. PubMed ID: 11771157 [TBL] [Abstract][Full Text] [Related]
39. Prosthetic treatment of a patient with facioscapulohumeral muscular dystrophy: a clinical report. Güler AU; Ceylan G; Ozkoç O; Aydiin M; Cengiz N J Prosthet Dent; 2003 Oct; 90(4):321-4. PubMed ID: 14564285 [TBL] [Abstract][Full Text] [Related]
40. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]